A novel approach based on the optimized multidrug combination for glioblastoma treatment.
2020/39/D/NZ7/00789
Keywords
Descriptors
- NZ7_014: Farmacja, farmakoterapia, farmakologia
- NZ5_007: Leczenie chorób człowieka
- NZ7_015: Toksykologia
Panel
NZ7 – Diagnostic tools, therapies and public health: public health, epidemiology, environmental health risks and occupational medicine, medical ethics, drug discovery and therapies, pharmacology
Host institution
Uniwersytet Medyczny im. Karola Marcinkowskiego w Poznaniu
Voivodeship: wielkopolskie
Principal investigator (from the host institution)
Number of co-investigators in the project: 6
Call
SONATA 16 – announced on 2020-09-15
- Amount awarded
- 1 726 935 PLN
- Project start date
- 2021-06-15
- Project end date
- 2027-06-14
- Project duration
- 72 months (the same as in the proposal)
- Project status
- Pending project
Project description
Download the project description in a pdf file
Note — project descriptions were prepared by the authors of the applications themselves and placed in the system in an unchanged form.
Information in the final report
Publication in academic press/journals (2)
-
The combination therapy using tyrosine kinase receptors inhibitors and repurposed drugs to target patient-derived glioblastoma stem cells
- Authors:
- Malgorzata Kucinska,, Julia Pospieszna, Jing Tang, Natalia Lisiak, Ewa Toton, Blazej Rubis, Marek Murias
- Academic press:
- Biomedicine and Pharmacotherapy (year: 2024, volume: 176, pages: 116892), Publisher: Elsevier
- Status:
- Published
- DOI:
- 10.1016/j.biopha.2024.116892 – link to the publication
-
Unmasking the Deceptive Nature of Cancer Stem Cells: The Role of CD133 in Revealing Their Secrets
- Authors:
- Julia Pospieszna, Hanna Dams-Kozlowska, Wachirawit Udomsak, Marek Murias, Malgorzata Kucinska
- Academic press:
- International Journal of Molecular Sciences (year: 2023, volume: 24, pages: 10910), Publisher: MDPI
- Status:
- Published
- DOI:
- 10.3390/ijms241310910 – link to the publication